According to the GHTF IVD guidance, which of the following is the CORRECT classification for a blood
glucose self-testing kit?

A global company has obtained a patent in a specific country for a newly marketed product. What would
be the BEST advice In order to protect the patent in other countries?

When applying for marketing approval of a drug for a rare disease, which requirement can be waived?

A process is ultimately validated to ensure which of the following?

A company is developing a novel drug to combat AIDS. The preliminary results are very promising and
include instances of complete remission. The company has been granted patents in multiple countries for
the drug. The regulatory affairs professional is asked to prepare a brief report concerning potential
problems for marketing of the product worldwide. Which of the following is the MOST important
consideration to discuss?